Francesc March de Ribot

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Vascular Endothelial Growth Factor

Optical Coherence Tomography

Diabetic Retinopathy

Top Venues

Journal of clinical medicine

European journal of ophthalmology

This page only lists publications with an associated author ORCID identifier.

Publications

Alper Bilgic, Laurent Kodjikian, Aditya Sudhalkar, Jesus Hernan Gonzalez-Cortes, Francesc March de Ribot, Riddhima Deshpande, Martin S Spitzer, Thibaud Mathis
Pro Re Nata brolucizumab for early onset and treatment-naïve diabetic macular edema: A prospective study. European journal of ophthalmology (2024)
Jesus H Gonzalez-Cortes, Victor A Martinez-Pacheco, Jesus E Gonzalez-Cantu, Alper Bilgic, Francesc March de Ribot, Aditya Sudhalkar, Jesus Mohamed-Hamsho, Laurent Kodjikian, Thibaud Mathis
Current Treatments and Innovations in Diabetic Retinopathy and Diabetic Macular Edema. Pharmaceutics 15 (1) (2022)
Jesus H Gonzalez-Cortes, Victor A Martinez-Pacheco, Jesus E Gonzalez-Cantu, Alper Bilgic, Francesc March de Ribot, Aditya Sudhalkar, Jesus Mohamed-Hamsho, Laurent Kodjikian, Thibaud Mathis
Current Treatments and Innovations in Diabetic Retinopathy and Diabetic Macular Edema. Pharmaceutics 15 (1) (2022)
Jesus H Gonzalez-Cortes, Victor A Martinez-Pacheco, Jesus E Gonzalez-Cantu, Alper Bilgic, Francesc March de Ribot, Aditya Sudhalkar, Jesus Mohamed-Hamsho, Laurent Kodjikian, Thibaud Mathis
Current Treatments and Innovations in Diabetic Retinopathy and Diabetic Macular Edema. Pharmaceutics 15 (1) (2022)
Jesus H Gonzalez-Cortes, Victor A Martinez-Pacheco, Jesus E Gonzalez-Cantu, Alper Bilgic, Francesc March de Ribot, Aditya Sudhalkar, Jesus Mohamed-Hamsho, Laurent Kodjikian, Thibaud Mathis
Current Treatments and Innovations in Diabetic Retinopathy and Diabetic Macular Edema. Pharmaceutics 15 (1) (2022)
Alper Bilgic, Laurent Kodjikian, Francesc March de Ribot, Vaishali Vasavada, Jesus Hernan Gonzalez-Cortes, Amro Abukashabah, Aditya Sudhalkar, Thibaud Mathis
Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study. Journal of clinical medicine 10 (13) (2021)